Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure

Alberto M. Marra, Michele Arcopinto, Andrea Salzano, Emanuele Bobbio, Salvatore Milano, Gabriella Misiano, Francesco Ferrara, Olga Vriz, Raffaele Napoli, Vincenzo Triggiani, Pasquale Perrone-Filardi, Francesco Saccà, Francesco Giallauria, Andrea M. Isidori, Carlo Vigorito, Eduardo Bossone, Antonio Cittadini

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)114-117
Number of pages4
JournalInternational Journal of Cardiology
Volume209
DOIs
Publication statusPublished - Apr 15 2016

Keywords

  • Chronic heart failure
  • Cytokines
  • Interleukin-9
  • Outcomes
  • Peak oxygen consumption
  • Risk stratification

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Marra, A. M., Arcopinto, M., Salzano, A., Bobbio, E., Milano, S., Misiano, G., Ferrara, F., Vriz, O., Napoli, R., Triggiani, V., Perrone-Filardi, P., Saccà, F., Giallauria, F., Isidori, A. M., Vigorito, C., Bossone, E., & Cittadini, A. (2016). Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure. International Journal of Cardiology, 209, 114-117. https://doi.org/10.1016/j.ijcard.2016.02.017